Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
3.530
+0.340 (10.66%)
At close: Jun 27, 2025, 4:00 PM
3.500
-0.030 (-0.85%)
After-hours: Jun 27, 2025, 7:47 PM EDT

Immuneering Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
12768215128426-
Upgrade
Market Cap Growth
-35.54%-68.25%67.99%-69.91%--
Upgrade
Enterprise Value
952212216267-
Upgrade
Last Close Price
2.772.207.354.8516.17-
Upgrade
PS Ratio
---404.05204.62-
Upgrade
PB Ratio
2.381.652.381.172.73-
Upgrade
P/TBV Ratio
3.651.992.581.252.86-
Upgrade
EV/Sales Ratio
---49.59128.17-
Upgrade
Debt / Equity Ratio
0.100.100.050.040.030.02
Upgrade
Asset Turnover
---0.000.020.09
Upgrade
Quick Ratio
7.024.8210.9213.1026.5316.66
Upgrade
Current Ratio
7.485.2811.3613.5027.0416.73
Upgrade
Return on Equity (ROE)
-102.48%-92.51%-53.36%-38.00%-35.00%-74.56%
Upgrade
Return on Assets (ROA)
-57.90%-51.57%-32.46%-22.38%-20.65%-40.66%
Upgrade
Return on Capital (ROIC)
-62.22%-56.97%-34.81%-23.43%-21.44%-42.85%
Upgrade
Earnings Yield
-48.63%-89.35%-24.86%-39.44%-7.88%-
Upgrade
FCF Yield
-42.23%-80.64%-22.92%-35.02%-7.26%-
Upgrade
Buyback Yield / Dilution
-8.14%-5.51%-7.69%-93.84%-175.00%0.00%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q